Fox Run Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$309K	Sell	22,121 -11,359	-34%	-$166K	0.05%	614
2025 Q4	$534K	Buy	33,480 +6,778	+25%	+$96.1K	0.08%	476
2025 Q3	$295K	Sell	26,702 -9,159	-26%	-$100K	0.05%	688
2025 Q2	$304K	Sell	35,861 -9,101	-20%	-$73K	0.05%	633
2025 Q1	$361K	Buy	44,962 +24,777	+123%	+$201K	0.06%	616
2024 Q4	$181K	Buy	+20,185	New	+$165K	0.03%	763
2024 Q3	–	Sell	-28,797	Closed	-$164K	–	795
2024 Q2	$164K	Buy	28,797 +1,545	+6%	+$8.14K	0.03%	694
2024 Q1	$137K	Buy	+27,252	New	+$185K	0.03%	685
2023 Q4	–	Sell	-15,391	Closed	-$120K	–	726
2023 Q3	$120K	Sell	15,391 -38,436	-71%	-$376K	0.04%	610
2023 Q2	$521K	Buy	+53,827	New	+$559K	0.15%	274
2023 Q1	–	Sell	-34,281	Closed	-$148K	–	650
2022 Q4	$148K	Buy	34,281 +6,788	+25%	+$39.4K	0.06%	526
2022 Q3	$207K	Buy	+27,493	New	+$238K	0.08%	470